22 May 2013
Keywords: Shre, Lialda, Ulcerative colitis, USA, FDA
Article | 19 July 2011
The US Food and Drug Administration has approved Ireland-headquartered specialty drugmaker Shire’s (LSE: SHP) Lialda (mesalamine) delayed-release tablets ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2011
20 July 2011
© 2013 thepharmaletter.com